1. Home
  2. NEXA vs ATAI Comparison

NEXA vs ATAI Comparison

Compare NEXA & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$10.00

Market Cap

1.6B

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$3.34

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
ATAI
Founded
1956
2018
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
NEXA
ATAI
Price
$10.00
$3.34
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$10.10
$15.57
AVG Volume (30 Days)
648.1K
4.6M
Earning Date
04-28-2026
03-06-2026
Dividend Yield
1.37%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$308,000.00
Revenue This Year
$6.99
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.62
$1.15
52 Week High
$14.94
$6.73

Technical Indicators

Market Signals
Indicator
NEXA
ATAI
Relative Strength Index (RSI) 43.20 39.71
Support Level $8.79 $3.06
Resistance Level $14.84 $4.30
Average True Range (ATR) 0.61 0.21
MACD -0.10 -0.03
Stochastic Oscillator 35.55 6.09

Price Performance

Historical Comparison
NEXA
ATAI

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: